Somatostatin infusion and hemodynamic changes in patients with non-variceal upper gastrointestinal bleeding: A pilot study

Medical Science Monitor

Volumn 9, Issue 7, 2003, Pages

  Saruç, Murat ^a,b,c   Can, Mine ^b   Küçükmetin, Nurten ^b   Tuzcuoglu, Isil ^b   Tarhan, Serdar ^b   Göktan, Cihan ^b   Yüceyar, Hakan ^b  

^a UNIVERSITY OF NEBRASKA MEDICAL CENTER   (United States)

^b CELAL BAYAR UNIVERSITY   (Turkey)

^c Merkez Efendi Mah   (Turkey)

Author keywords

Bleeding; Doppler; Peptic ulcer; Somatostatin

Indexed keywords

SOMATOSTATIN;

ADULT; ARTERY BLOOD FLOW; ARTERY RESISTANCE; ARTICLE; BLOOD FLOW VELOCITY; CLINICAL ARTICLE; CONTROLLED STUDY; DOPPLER ECHOGRAPHY; DRUG EFFECT; DRUG EFFICACY; DRUG INFUSION; FEMALE; HEMODYNAMICS; HUMAN; INTESTINE BLOOD FLOW; KIDNEY ARTERY; MALE; PEPTIC ULCER BLEEDING; PILOT STUDY; PORTAL VEIN BLOOD FLOW; PULSE WAVE; STOMACH BLOOD FLOW; SUPERIOR MESENTERIC ARTERY; UPPER GASTROINTESTINAL BLEEDING;

ADULT; DUODENUM; ESOPHAGEAL AND GASTRIC VARICES; GASTROINTESTINAL HEMORRHAGE; HEMODYNAMIC PROCESSES; HORMONES; HUMANS; MALE; MIDDLE AGED; PILOT PROJECTS; REGIONAL BLOOD FLOW; SOMATOSTATIN; STATISTICS; STOMACH; TREATMENT OUTCOME;

EID: 0041468954     PISSN: 12341010     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Mottet C, Sieber CC, Nauer A et al: Hemodynamic effects of the somatostatin analog lanreotide in humans: placebo-controlled, cross-over, dose-ranging Echo-Doppler study. Hepatology, 1998; 27(4): 920-5
2. Ludwig D, Schadel S, Bruning A et al: 48-hour hemodynamic effects ocreotide on postprandial splanchnic hyperemia in patients with liver cirrhosis and portal hypertension. Dig Dis Sci, 2000; 45: 1019-27
3. Etherington DJ, Taylor WH: Nomenclature of pepsins (abstract). Nature, 1967; 216: 279-80
4. D'Amico G, Montalbano L, Traina M et al: Natural history of congestive gastropathy in cirrhosis. Gastroenterology, 1990; 99: 1558-64
5. Kubba AK, Dallal H, Haydon GH et al: The effect of ocreotide on gastroduodenal blood flow measured by laser Doppler flowmetry in rabbits and man. Am J Gastroenterol, 1999; 94: 1077-82
6. Panes J, Bordas J, Pique J et al: Increased gastric mucosal perfusion in cirrhotic patients with portal hypertensive gastropathy. Gastroenterology, 1992; 103: 1875-82
7. Becker RHA, Scholtolt J, Scholkens BA et al: A microsphere study on the effects of somatostatin and secretin on regional blood flow in anaesthetised dogs (abstract). Regul Pept, 1982; 4: 341-51
8. Starlinger M, Mathews J, Yoon CH et al: The effect of acid perfusion on mucosal blood flow and intramural pH of rabbit duodenum. Surgery, 1987; 101: 433-9
9. Sonnenberg A, West C: Somatostatin reduces gastric mucosal blood flow in normal subjects but not in patients with cirrhosis of the liver. Gut, 1983; 24: 148-53
10. Gana TJ, Huhlewych R, Koo J: Focal gastric mucosal blood flow by laser Doppler and hydrogen gas clearance: A comparative study. J Surg Research, 1987; 43: 337-43
11. Lunde OC, Kvernebo K, Hanssen LE, Larsen S: Effect of somatostatin on human gastric blood flow evaluated by endoscopic laser Doppler flowmetry. Scand J Gastroenterol, 1987; 22: 842-6
12. Lunde OC, Kvernebo K: Gastric blood flow in patients with gastric ulcer measured by endoscopic laser Doppler flowmetry. Scand J Gastroenterol, 1988; 23: 546-50
13. Walker V, Taylor WH: Pepsin 1 secretion in chronic peptic ulceration. Gut, 1980; 21: 776-81
14. Pearson JP, Ward R, Allen A et al: Mucus degradation by pepsin 1: comparison of mucolytic activity of human pepsin 1 and pepsin 3: implications in peptic ulceration. Gut, 1986; 27: 243-8
15. + back diffusion stimulates gastric mucosal blood flow in the rabbit fundus. Surgery, 1981; 89: 232-6